Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
FimmCyte is a biotechnology company that engages in the research and treatment of chronic endometriosis disease.
Akasi Pharma focuses on developing peptide-based therapeutics aimed at treating peripheral pain conditions.
3Sonic is a Med-Tech startup company that has developed a novel 3D imaging device to improve precision in cancer surgery
Fuse Vectors is disrupting the manufacturing process in order to provide universal access to gene therapy.
Incipiam Pharma focuses on developing innovative treatments for metabolic diseases by targeting energy expenditure.
NanoGuard Crop is a biotechnology company focused on developing next-generation, eco-friendly biopesticides for sustainable crop protection.
Xterna is an engineering biology firm producing molecular binders that can identify certain cell types for medication delivery solutions.
Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections.
Cambiotics mission is to reducing the widespread presence of chemicals in the body whc are spread through various everyday products.
MyoPax creates advanced regenerative stem cell therapies to combat the devasting effects of muscle illnesses.
TetraKit Technologies is a click chemistry-based radiochemical platform developing therapeutics for metastatic cancer.
Droplet IV here to create better patient outcomes and reduce the burden of nurses by building the futur of IV infusion therapy.
Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.
SaaS, biotech, dna, genomics, diagnostics
First-in-class hardware-and-software-as-a-service diagnostics for the 400M suffering from middle ear problems
HHC Medical is a health tech company developing targeted non-invasive drug delivery devices.
Ward 24/7 develops a wireless assessment of respiratory and circulatory distress to monitor and observe high-risk patients.
BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.
Kesmalea Therapeutics is a biotech startup focusing on the discovery of novel protein degraders.
Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.
Bioomix is a biotechnology company that develops all-natural microbial products that can help farmers achieve a higher and better yield.
MATR Foods is a food-tech startup that provides fungi-based food ingredients.
Ampa Medical provides healthcare services for people living with an ostomy.
Producing tomorrow´s sustainable protein and omega-3 rich products utilizing captured CO2, microalgae, and a win-win business model.
BioInnovation Institute has invested in 141 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
BioInnovation Institute's top investment sectors include Biotechnology, Medical, Health Care, Medical Device, Therapeutics. The firm invests across 22 different industry categories.
Among tracked funding rounds, MATR Foods received $23.2M in a Series A round. BioInnovation Institute's total known invested capital is $314.9M.
BioInnovation Institute's average investment size is $4.0M across its portfolio of 141 companies.
Recent BioInnovation Institute portfolio additions include FimmCyte, Akasi Pharma, 3Sonic, Fuse Vectors, Incipiam Pharma. These companies were founded in 2020 or later.